RPT193

RAPT Therapeutics announces initiation of first-in-human phase 1 study of RPT193
Pharmaceutical Business Review
Thu, 10/24/19 - 10:13 am
RAPT Therapeutics
RPT193
allergies
atopic dermatitis
clinical trials